Quest Diagnostics

AMRI

AMRI, PerkinElmer collaborate on Buffalo Medical Hub

Friday, June 19, 2015 12:14 PM

Global CRO Albany Molecular Research (AMRI) and CRO PerkinElmer are collaborating in connection with the opening of AMRI's drug discovery center as part of the new Buffalo Medical Innovation and Commercialization Hub (BMIC). Co-located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, the Hub will accelerate drug discovery and innovation, and ultimately support the creation of more than 250 high tech jobs.

More... »


CPhI Pharma Awards 2015 open with five new categories

Monday, June 15, 2015 01:38 PM

CPhI Worldwide, organized by UBM EMEAhas opened the annual CPhI Pharma Awards for 2015, with five new categories covering the entire pharmaceutical supply chain. Now in their 12th consecutive year, the awards will honor companies and individuals driving the pharma industry forward through innovations, new approaches, technologies and strategies.  

More... »


AMRI, HarkerBIO collaborate

Friday, June 5, 2015 11:07 AM

Albany Molecular Research (AMRI), a CRO based in Albany, N.Y., has signed a collaborative agreement with Buffalo, N.Y.-based biotechnology company HarkerBIO to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients. AMRI gains access to HarkerBIO's differentiated high-resolution, structure-determination experience and capabilities. HarkerBIO's customers will be able to access and benefit from AMRI's global capabilities, including their integrated drug discovery platforms and solutions.

More... »

AMRI to shutter U.K. facility, lay off 62 workers

Monday, April 6, 2015 12:00 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has decided to close its Holywell, U.K., facility, which provides chemical development services and small- and large-scale manufacturing services of active pharmaceutical ingredients (API) and intermediates.

More... »

AMRI hires VP of International Sales

Thursday, March 5, 2015 11:14 AM

Albany Molecular Research (AMRI), a global CRO based in Albany, N.Y., has hired Michael Pettersson to fill the newly created position of vice president of International Sales, effective immediately. He reports to Christopher Conway, senior vice president of Global Sales and Marketing.

More... »

AMRI hires Jimmy Wang as chief information officer

Wednesday, February 11, 2015 02:46 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has hired Jimmy Wang, Ph.D., to fill the newly created position of chief information officer, effective immediately. He replaces Carl Neumann, senior director, information technology, who retires this month.

More... »

AMRI announces CFO transition

Friday, January 16, 2015 10:50 AM

Michael M. Nolan, senior vice president and chief financial officer, will be departing Albany Molecular Research (AMRI), a global contract research and manufacturing organization. Nolan will remain with AMRI through February 2015 to support an orderly transition. Felicia Ladin will join the company in the same role, effective Feb. 4, 2015.

More... »

AMRI to acquire Aptuit drug development, aseptic manufacturing businesses

Friday, January 9, 2015 02:01 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has acquired the outstanding equity interests of Aptuit's Glasgow, U.K., business and has entered into a definitive agreement to acquire Aptuit's SSCI/West Lafayette, Ind., business, for a total of $60 million, expanding AMRI's drug product development and aseptic clinical manufacturing capabilities.

More... »

AMRI's expands discovery biology offerings

Monday, September 8, 2014 01:52 PM

Albany Molecular Research (AMRI), a New York-based global CRO, has expanded into the protein market, with an initial focus on protein expression and purification. The global revenue of the total proteomics market is anticipated to grow at a compound annual growth rate of about 4.1% to about $9.2 billion by 2018.

More... »

AMRI completes acquisition of Oso Biopharmaceuticals Manufacturing

Friday, July 4, 2014 10:00 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has completed the acquisition of Oso Biopharmaceuticals Manufacturing, a former portfolio company of Altaris Capital Partners.

More... »


CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs